By Benjamin Chiou
Date: Friday 23 May 2025
(Sharecast News) - Healthcare property investment and management firm Assura has delayed an upcoming shareholder vote on the takeover proposal from KKR and Stonepeak as it assesses a competing proposal from Primary Health Properties.
Form 8.3 - Primary Health Properties plc | 23-May-2025 | 17:56 | Business Wire |
Form 8.3 - Primary Health Properties plc | 23-May-2025 | 15:42 | RNS |
Form 8.5 (EPT/RI)- Primary Health Properties Amend | 23-May-2025 | 15:41 | RNS |
Form 8.3 - Primary Health Properties Plc | 23-May-2025 | 15:21 | GlobeNewswire NA |
Form 8.3 - Primary Health Properties plc | 23-May-2025 | 15:20 | RNS |
Nine property companies poised to convert to Reits | 31-Dec-2006 | Sunday Telegraph |
Questor:Primary Health Properties | 23-Nov-2011 | Telegraph |
Questor :Primary Health Properties | 20-Apr-2011 | Telegraph |
Questor : Primary Health Properties | 08-Dec-2010 | Telegraph |
Dividends are the key to a sensible investment s... | 28-Dec-2009 | Sunday Telegraph |
Questor: Primary Health Properties | 31-Aug-2009 | Sunday Telegraph |
No recent information was found.
Currency | UK Pounds |
Share Price | 98.70p |
Change Today | 0.050p |
% Change | 0.05 % |
52 Week High | 103.50 |
52 Week Low | 86.15 |
Volume | 7,851,139 |
Shares Issued | 1,336.49m |
Market Cap | £1,319.12m |
Beta | 0.02 |
RiskGrade | 84 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 2 |
Buy | 1 |
Neutral | 3 |
Sell | 0 |
Strong Sell | 0 |
Total | 6 |
Latest | Previous | |
---|---|---|
Q2 | Q1 | |
Ex-Div | 27-Mar-25 | 09-Jan-25 |
Paid | 09-May-25 | 21-Feb-25 |
Amount | 1.77p | 1.77p |
Time | Volume / Share Price |
15:01 | 1 @ 98.45p |
15:01 | 1 @ 98.45p |
15:01 | 1 @ 98.45p |
15:01 | 1 @ 98.45p |
15:01 | 1 @ 98.45p |
CFO | Richard Howell |
CEO | Mark Davies |
You are here: research